echoloc

Spore.Bio Tech Stack

AI-powered biophotonics platform for rapid microbiology diagnostics

Industrial Machinery Manufacturing Paris, Île-de-France 51–200 employees Founded 2023 Privately Held

Spore.Bio applies deep learning (PyTorch, Vision Transformers, Hugging Face) to biophotonic imaging—a physics-based sensor modality for microbial analysis. The stack reveals a research-heavy org (5 researchers vs. 1 engineer) still in platform-building phase, with infrastructure (AWS/GCP/Azure, Terraform, Docker) and LIMS integration suggesting they're moving beyond lab prototype toward clinical or industrial deployment. Core friction: traditional microbiology workflows are slow and constrained; Spore targets AMR (antimicrobial resistance) diagnostics as a speed-critical use case.

Tech Stack 22 technologies

Core StackPyTorch Hugging Face pandas FastAPI AWS Python PostgreSQL Terraform Ansible Docker Django GitHub Actions GitLab CI/CD Lightning Vision Transformers GCP Azure R Excel LIMS deep learning Raman spectroscopy

What Spore.Bio Is Building

Challenges

  • Reducing amr diagnostic time
  • Heavy constraints and long waiting times
  • Slow traditional microbiological workflows
  • Expanding into new markets
  • Ensuring product safety
  • Long waiting times for quality control
  • Heavy constraints in traditional quality control
  • Cost structure optimization
  • Slow microbiology workflows
  • Managing cash flow during scaling

Active Projects

  • Biophotonics imaging analysis platform
  • Spore.labs amr diagnostic program
  • Cutting-edge data science solution
  • Future of industrial microbiology
  • Microbiology experiment design
  • Industrial protocol translation
  • Expansion into france and us
  • Financial modeling tool development
  • Procurement process redesign
  • Biophotonic imaging platform development

Hiring Activity

Steady10 roles · 4 in 30d

Department

Research
5
Finance
2
Data
1
Engineering
1
Ops
1
Sales
1

Seniority

Mid
5
Senior
5
Lead
1
Company intelligence

Find more companies like Spore.Bio by tech stack, pain points and active projects

Get started free

About Spore.Bio

Spore.Bio develops microbiological diagnostic technologies combining AI and light-based sensing. Founded in 2023 and based in Paris, the company is building a biophotonics imaging analysis platform aimed at reducing diagnostic turnaround time in settings where traditional quality control and pathogen detection are bottlenecks—particularly antimicrobial resistance screening. Their projects span diagnostic software (the Spore.Labs AMR program), experiment design tooling, industrial protocol translation, and infrastructure for financial modeling and procurement. The organization is actively expanding into France and North America.

HeadquartersParis, Île-de-France
Company Size51–200 employees
Founded2023
Hiring MarketsFrance, Canada

Frequently Asked Questions

What is Spore.Bio's tech stack?

PyTorch, Vision Transformers, Hugging Face, FastAPI, PostgreSQL, Docker, Terraform, AWS/GCP/Azure, LIMS integration, and Raman spectroscopy for biophotonic sensor processing.

What is Spore.Bio working on?

Biophotonics imaging analysis platform, AMR (antimicrobial resistance) diagnostics via Spore.Labs, industrial microbiology protocols, and geographic expansion into France and the US.

Similar Companies in Industrial Machinery Manufacturing

Other companies in the same industry, closest in size